Strata Critical Medical, Inc.
SRTA Healthcare Medical Care Facilities
In the quarter to June 2026, revenue grew 60.7%, EPS fell 140.0% and free cash flow grew 150.3%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
Follow SRTA
Strata Critical Medical, Inc. (SRTA) EV/Sales
As of 16 October 2026, Strata Critical Medical, Inc. (SRTA) trades at a EV/Sales of 1.4×. Over the past ten years it has ranged from −0.6× (January 2022) to 7.7× (November 2021); the current reading is higher than 72% of that period. That is above the Medical Care Facilities industry median of 1.3× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 1.7× | 21.53% |
| FY2024 | 1.4× | 275.55% |
| FY2023 | 0.4× | 18.67% |
| FY2022 | 0.3× | (75.58%) |
| FY2021 | 1.3× | (81.49%) |
| FY2021 | 6.9× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 1.7× | 29.42% |
| Mar 2026 | 1.3× | (23.00%) |
| Dec 2025 | 1.7× | (39.68%) |
| Sep 2025 | 2.8× | 42.93% |
| 20 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| MCTA Charming Medical Limited compare | n/m |
| AIRS AirSculpt Technologies, Inc. compare | 0.8× |
| CYH Community Health Systems, Inc. compare | 0.8× |
| AUNA Auna S.A. compare | 1.0× |
| INNV InnovAge Holding Corp. compare | 1.1× |
| STLN Starling Oncology, Inc. compare | 1.2× |
| SRTA Strata Critical Medical, Inc. | 1.4× |
| NUTX Nutex Health Inc. compare | 1.6× |
| USPH U.S. Physical Therapy, Inc. compare | 1.8× |
| Medical Care Facilities industry median | 1.3× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)